United States · FDA National Drug Code directory
Tri-Estarylla
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70700-121_e43facd8-dbf3-de33-00f7-d8e7fe7156dc
- Product NDC
- 70700-121
- Form
- KIT
- Composition / generic term
- norgestimate and ethinyl estradiol
- Labeler
- Xiromed, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220901
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (70700-121-85) / 1 KIT in 1 BLISTER PACK · 70700-121-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →